Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Context Therapeutics Inc (CNTX)

  7. Context Therapeutics Inc (CNTX) Financials

CNTX

Context Therapeutics Inc

0.87
-0.11 (-11.22%)
Upgrade to Real-Time

Context Therapeutics Inc. (CNTX) Fundamentals
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.
SHARE INFORMATION
Market Cap$ 15,646,732
Shares Outstanding15,966,053
Float13,590,000
Percent Float85.12%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.40
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions45
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months141,419
Institutional Holdings Percent37.8%
Institutional Sold Previous 3 Months369,244
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months37,118
Insider Holdings Percent1.9
Insider Sold Previous 3 Months-
Insider Shares Owned307,973
TRADING INFO
52 Week High$ 2.52
52 Week Low$ 0.47
52 Week High Change$ -52.20
21 Day Moving Average$ 0.6294
21 Day Extended Moving Average$ 0.68352
50 Day Moving Average$ 0.6185
50 Day Extended Moving Average$ 0.66096
200 Day Moving Average$ 0.991573
200 Day Extended Moving Average$ 1.0612
10 Day Average Volume312,085
20 Day Average Volume212,655
30 Day Average Volume162,979
50 Day Average Volume132,935
Alpha-0.053270
Beta2.2684
Standard Deviation0.331728
R20.162337
7 Day Price Change$ 0.282
7 Day Percent Change40.4%
21 Day Price Change$ 0.3796
21 Day Percent Change63.22%
30 Day Price Change$ 0.3989
30 Day Percent Change68.65%
Month to Date Price Change$ 0.3989
Month to Date Percent Change68.65%
Quarter to Date Price Change$ 0.4178
Quarter to Date Percent Change74.32%
180 Day Price Change$ -0.40
180 Day Percent Change-28.99%
200 Day Price Change$ -0.25
200 Day Percent Change-20.33%
Year to Date Price Change$ 0.3283
Year to Date Percent Change50.38%

Context Therapeutics Inc. (CNTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio9.90
Leverage Ratio1.70
Quick Ratio9.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ -8,624,026
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.80
Price To Cash Flow-0.60
PE Low Last 5 Years0.00
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-44.82
Return on Equity-55.22
Return on Capital-48.75

Context Therapeutics Inc. (CNTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOMartin Lehr
Employees7
Last Audit-
CIK0001842952
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2001 Market Street, Unit No 15,Suite 3915
Suite 3915, Unit No. 15
Philadelphia, PA 19103
Websitehttps://www.contexttherapeutics.com
Facsimile-
Telephone+1 267 225-7416
Email-


Your Recent History
NASDAQ
CNTX
Context Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.